Haidong M Dong, MD, PhD

Professor, Rochester, MN, Urology

EmailDong.Haidong@mayo.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Haidong M Dong is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

4 Finished

A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR
Park, S., Park, S. S. & Dong, H. M.
National Cancer Institute
2/9/16 → 1/31/19
Project: Research project
Role of Bim and soluble B7-H1 in monitoring T cell responses to anti-PD-1 therapy in melanoma
Dong, H. M., Dronca, R., Dronca, R. S. & Dronca, R. S.
National Cancer Institute
8/17/15 → 7/31/17
Project: Research project
Functional B7-H1 expressed by T cells
Dong, H. M. & Kinney, L.
National Institute of Allergy and Infectious Diseases
6/1/14 → 5/31/19
Project: Research project
Clinical Impact of B7-H Immune Cell Coregulators in Renal Cell Carcinoma
Dong, H. M., Kwon, E. D., Kinney, L. & Kinney, L.
National Cancer Institute
12/1/08 → 12/31/15
Project: Research project

16989 Citations
50 Scopus h-Index
103 Article
11 Review article
7 Comment/debate
5 Editorial
More

Case Report: Simultaneous Hyperprogression and Fulminant Myocarditis in a Patient With Advanced Melanoma Following Treatment With Immune Checkpoint Inhibitor Therapy
Barham, W., Guo, R., Park, S. S., Herrmann, J., Dong, H. & Yan, Y., Feb 2 2021, In: Frontiers in immunology. 11, 561083.
Research output: Contribution to journal › Article › peer-review

Open Access
Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma
Bearrick, E. N., Packiam, V., Bhindi, B., Lohse, C. M., Cheville, J. C., Mason, R. J., Tollefson, M., Harrington, S., Dong, H., Parker, A. S., Boorjian, S. A., Thompson, R. H. & Leibovich, B. C., Feb 2021, In: Urologic Oncology: Seminars and Original Investigations. 39, 2, p. 135.e1-135.e8
Research output: Contribution to journal › Article › peer-review
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
Wang, Y., Sinha, S., Wellik, L. E., Secreto, C. R., Rech, K. L., Call, T. G., Parikh, S. A., Kenderian, S. S., Muchtar, E., Hayman, S. R., Koehler, A. B., Van Dyke, D. L., Leis, J. F., Slager, S. L., Dong, H., Kay, N. E., He, R. & Ding, W., May 2021, In: Blood cancer journal. 11, 5, 86.
Research output: Contribution to journal › Article › peer-review

Open Access
Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma
Kankeu Fonkoua, L. A., Chakrabarti, S., Sonbol, M. B., Kasi, P. M., Starr, J. S., Liu, A. J., Nevala, W. K., Maus, R. L., Bois, M. C., Pitot, H. C., Chandrasekharan, C., Ross, H. J., Wu, T. T., Graham, R. P., Villasboas, J. C., Weiss, M., Foster, N. R., Markovic, S. N., Dong, H. & Yoon, H. H., Jul 15 2021, In: International Journal of Cancer. 149, 2, p. 378-386 9 p.
Research output: Contribution to journal › Article › peer-review
PD-L1 tumor-intrinsic signaling and its therapeutic implication in triple-negative breast cancer
Chen, C., Li, S., Xue, J., Qi, M., Liu, X., Huang, Y., Hu, J., Dong, H. & Ling, K., Apr 1 2021, In: JCI Insight. 6, 8, e131458.
Research output: Contribution to journal › Article › peer-review

Open Access